Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.

T Ristriani1, M Masson, Y Nominé

  • 1Laboratoire d'Immunotechnologie, UPRES 1329, Ecole Superieure de Biotechnologie de Strasbourg, Illkirch, 67400, France.

Journal of Molecular Biology
|March 4, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Thrombodynamics® analyzer: A new thrombin generation analyzer compared to the Calibrated Automated Thrombogram® in liver transplantation.

Thrombosis research·2019
Same author

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).

HIV medicine·2018
Same author

Antithymocyte globulin-induced hemolytic anemia and thrombocytopenia after kidney transplantation.

Immunotherapy·2018
Same author

Point-shear wave elastography predicts liver hypertrophy after portal vein embolization and postoperative liver failure.

Diagnostic and interventional imaging·2018
Same author

Liver Transplantation With Old Grafts: A Ten-Year Experience.

Transplantation proceedings·2017
Same author

Effect of orthopedic implants on long bone properties: a combined experimental and numerical approach.

Computer methods in biomechanics and biomedical engineering·2017

High-risk human papillomavirus (HPV) oncoprotein E6 binds selectively to four-way DNA junctions. This discovery suggests novel mechanisms for E6

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • The E6 oncoprotein from high-risk human papillomaviruses (HPVs) is linked to cervical cancers.
  • E6 is known to promote tumorigenesis by degrading the tumor suppressor p53.
  • Potential alternative functions of E6, suggested by sequence similarity to phage T4 endonuclease VII, were unexplored.

Purpose of the Study:

  • To investigate the potential DNA-binding activity of HPV E6 proteins.
  • To determine if E6 interacts with DNA structures, specifically four-way junctions.
  • To elucidate the structural basis and functional implications of E6-DNA interactions.

Main Methods:

  • Purification of recombinant high-risk HPV E6 proteins.
  • Electrophoretic analysis of E6 protein interactions with DNA substrates, including four-way junctions.

Related Experiment Videos

  • Structure-dependent binding assays to characterize E6-DNA complex formation.

    • Main Results:

    • High-risk HPV E6 proteins were purified and demonstrated selective binding to four-way DNA junctions.
    • Binding is structure-dependent, with key residues in the C-terminal zinc-binding domain being essential.
    • E6 binds as a monomer, and the complexes adopt an extended square conformation.
    • Magnesium ions inhibit migration of E6-DNA complexes but not their equilibrium formation.

    Conclusions:

    • This study provides the first evidence of purified, active E6 binding specifically to a DNA ligand (four-way junctions).
    • The findings suggest novel, non-canonical roles for E6 in oncogenesis beyond p53 degradation.
    • E6's interaction with DNA structures may represent a new therapeutic target or diagnostic marker.